A delay in the vaccine trials IMO is probably not a bad thing.
If BARD 1 had no effect they would know that already IMO.
The company has already said there were some signs of delayed tumour growth in mesothelioma.
If they can improve someone's life expectancy even for 12 months that is a very big positive IMO. DB
Possible distribution or partnerships/ takeovers (Hypothetical only), page-84
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
